五鼎生物技術股份有限公司


History

2016 Apr. - Passed 4th FDA on-site inspection

2015 Oct. - Outstanding Category Awards of APEA 2015 ( Asia Pacific Entrepreneurship Awards )

2014 Dec. - Authorized Economic Operator (AEO) by Customs Admin, Ministry of Finance

2013 Feb. - 1st Taiwan MITTELSTAND Award from the MOEA

2012 Jan. - FDA approval of「CAL-1A」

2011 Apr. - FDA approval of AutoSure Voice 3 system

2010 Jan. - Local ERP system changed into Oracle JDE

2009 Mar. - to be selected Taiwan A+ Entrepreneur by Global Views

2008 Mar. - FDA 510 (k) approval of the GlucoSure Voice Blood Glucose Monitoring System

2007 Oct. - Awarded by Forbes Asia as "200 Best under a billion"

2006 Oct. - Awarded by Forbes Asia as "200 Best under a billion"

2005 July - Move-in New Facility

2004 Aug. - Co-Development of Bioluminescence Microsystems with ITRI

2003 Nov. - Purchasing of a new facility (23,867 M2)

2002 May - MultiSure Glucose & Uric Acid System Product Launch

2001 Sept. - Listed on the Taiwan Stock Exchange (stock code 1733)

2000 June - Listed on the Taiwan Over-The-Counter Securities Exchange

1999 April - GlucoSure Blood Glucose Monitoring System launch

1998 Nov. - Sensorex Blood Monitoring System wom "Product of the year" on Mediphar, Taipei

1997 Dec. - ApexBio founded in HsinChu Science Park

1996 June - Sensores system won "Gold National Award of Excellence"
五鼎生物技術 ApexBio Taiwan